Primary antibodies were diluted in Licor blocking solution/PBST with a final Tween-20 concentration of 0.1%, except for anti-phospho Aurora and anti-Histone H3S10ph, which had no Tween-20. The following antibodies and antibody dilutions were used: anti-INCENP (raised against C-terminal peptide CSNRHHLAVGYGLKY) (5.5 μg/ml), anti-Aurora B (Kelly et al., 2007 ; 5 μg/ml), anti-Borealin-2 (Dasra A; Kelly et al., 2007
; 5 μg/ml), anti-Survivin (Tseng et al., 2010
; 12 μg/ml), anti-phospho Aurora (Phospho-Aurora A [Thr288]/Aurora B [Thr 232]/Aurora C [Thr198] 2914, Cell Signaling Technology; 1:200), anti-Histone H3S10ph (6G3, 9706, Cell Signaling Technology; 1:500), anti-Histone H3T3ph (2162-1, Epitomics; 1:10,000), anti-GFP (11814460001, Sigma Aldrich; 1:1000), anti-PP2A-C (05-421, Millipore; 1:1000), Sgo1 (Boyarchuk et al., 2007
; 1:250), and anti-alpha-tubulin (DM1, Sigma; 1:20,000). Secondary antibodies from Licor were used (Licor goat anti-Rabbit 800 nm and Licor goat anti-mouse 680 nm), as was the Licor imaging system to scan membranes.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.